Skip to main content
logo
Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.20
+0.37 (2.84%)
Apr 14, 2026, 1:19 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Net Revenue
1.75B1.69B
Affordable Medicines Net Revenue Growth
3.58%14.53%
Specialty Net Revenue
528.51M445.75M
Specialty Net Revenue Growth
18.57%14.16%
AvKARE Net Revenue
744.73M662.95M
AvKARE Net Revenue Growth
12.34%24.67%
Revenue (Other)
4.00K6.00K
Revenue (Total)
3.02B2.79B
Revenue (Total) Growth
8.05%16.73%

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Gross Profit
683.92M673.90M
Affordable Medicines Gross Profit Growth
1.49%20.87%
Specialty Gross Profit
282.59M242.93M
Specialty Gross Profit Growth
16.33%37.89%
AvKARE Gross Profit
146.79M103.61M
AvKARE Gross Profit Growth
41.68%19.29%
Gross Profit (Other)
2.00K2.00K
Gross Profit (Total)
1.11B1.02B
Gross Profit (Total) Growth
9.10%24.36%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Operating Income
380.80M270.10M
Affordable Medicines Operating Income Growth
40.98%-2.20%
Specialty Operating Income
116.00M113.58M
Specialty Operating Income Growth
2.13%73.94%
AvKARE Operating Income
83.62M42.90M
AvKARE Operating Income Growth
94.90%36.14%
Corporate and Other Operating Income
-186.32M-177.26M
Operating Income (Total)
394.10M249.33M
Operating Income (Total) Growth
58.06%22.00%
Updated Feb 27, 2026. Data Source: Fiscal.ai.